Psynary
PHARMACEUTICAL RESEARCH

Digital Endpoints for Clinical Trials

Real-time monitoring of medication efficacy and side effects.

Pharmaceutical research laboratory with scientists

Features Grid

Digital endpoints and real-time monitoring for pharmaceutical clinical trials.

Digital Endpoints

Validated measures of depression & anxiety.

Rapid Non-Response Detection

Within 4–6 days.

Post-Marketing Surveillance

Real-world evidence generation.

Evidence Section

Olanzapine and Lithium outcome data collected via Psynary supported research into early response patterns.

Digital endpoints for depression and anxiety trials
Real-time medication efficacy and side effect monitoring
Phase IV and post-marketing study support

Medication Effectiveness Tracking

Medication effectiveness interface showing lamotrigine dosage adjustments and outcomes, plus Quetiapine and Lurasidone trials
Dosage TrackingTreatment Response

Benefits

Reduced Trial Costs

Faster recruitment and early efficacy detection reduce overall costs.

Higher-Quality Regulatory Submissions

Digital endpoints provide robust data for regulatory approval.

Continuous Monitoring Beyond Phase IV

Post-marketing surveillance and real-world evidence generation.

Accelerate Drug Development

Collect structured patient-reported data to support trial timelines, data quality, and researcher review with Psynary's digital data collection platform.

50%
Faster Patient Enrollment
Through streamlined digital data collection
90%
Data Completeness Rate
Structured collection reduces missing data
6 Days
Early Response Data Available
Structured data to inform researcher review

Integrate Psynary into your next trial

Partner with Psynary to collect structured patient-reported data for clinical trials and post-marketing studies.